CULTIVARIUM · RADIO
← On air
Today in Biology

Today in Biology — Aug 4

Today in Biology · with Sofia & Daniel · Recorded Aug 4, 2026
More episodes → Share on X Read the paper →
Transcript

[SOFIA] Alright, let's dive into what's shaping the landscape of biological engineering right now. And honestly, the biggest story this week, the one that’s going to impact pretty much everyone doing science in the US, is the Department of Energy’s Genesis Mission.

[DANIEL] Hmph. "Genesis Mission." Sounds… ambitious.

[SOFIA] It absolutely is. We're talking about a massive, multi-agency push to integrate AI across science and engineering. And when I say massive, I mean *five billion dollars* committed, with 278 projects already selected. It’s not just about building bigger computers; it’s about fundamentally changing how we approach scientific discovery.

[DANIEL] Five billion dollars is a significant sum, certainly. But "AI for science" can be a very broad brush. What does that actually mean for the folks in the labs, particularly in biology? Are we talking about better image analysis, or something more foundational?

[SOFIA] That’s a great question, Daniel, and it’s why this is so important for engineering biology. The Genesis Mission is really pushing AI as a *tool for discovery*, not just data processing. Think about it: designing novel proteins, optimizing metabolic pathways in microbes, even predicting how an organism will respond to environmental changes. We're moving beyond traditional computational biology to generative AI for biological design and prediction. The goal is to accelerate the design-build-test-learn cycle. And the DOE isn't just funding academic projects; they're bringing in national labs and tech companies, too.

[DANIEL] So, instead of just analyzing existing data, the AI is helping *generate* hypotheses or even *design* experiments and molecules? That's a different level of integration. I'd be interested to see the specifics on how these models are being validated – what are the controls here? Are we seeing these AI-designed pathways actually perform as predicted in a wet lab? Because the gap between in silico and in vivo can be substantial.

[SOFIA] Exactly. And while the announcements are still rolling out, what we’re seeing is a strong emphasis on nuclear research getting a big slice of that funding pie. But the larger implication is that if you’re doing any kind of engineering in biology, particularly with non-model organisms or complex systems, AI is no longer a niche tool; it's becoming a central pillar of how these large-scale initiatives are framed. It’s where the money is flowing, and it's where the national labs are focusing their efforts. The discussion online, especially from the Department of Energy, is framing this as the "Golden Age of American nuclear energy" and a way to "lead the AI race."

[DANIEL] That leads us to another significant development, one that affects the funding landscape directly. There's been some noticeable turbulence around science funding policy, specifically concerning proposed changes to how research grants are administered.

[SOFIA] Right. We’re seeing a pretty strong bipartisan pushback from the Senate against proposed White House changes that could give political appointees more control over grantmaking. There's a stopgap funding bill that aims to temporarily halt these changes.

[DANIEL] And this is crucial for researchers, because any shift that introduces more political influence into the scientific review process could fundamentally alter the types of projects that get funded, potentially prioritizing short-term political objectives over long-term scientific merit. It's about maintaining the integrity and independence of peer review.

[SOFIA] It’s a real tug-of-war over who decides what science gets done and how. And for engineering biology, where long-term, foundational research is often needed before application, stability in funding mechanisms is absolutely vital. You can’t build robust new tools or engineer complex systems if the ground keeps shifting under your feet every budget cycle. So, while Genesis offers a huge new opportunity, this policy debate is a reminder that the underlying mechanisms for *all* science funding are always under scrutiny.